Role of IV Immunoglobulin in Indian Children With Guillain-Barré Syndrome*

Conclusions:
In Indian children with Guillain-Barré syndrome, the outcome at 6 months in IV immunoglobulin treated group was similar to non-IV immunoglobulin group. Children with acute motor axonal neuropathy responded better to IV immunoglobulin.

Source: Pediatric Critical Care Medicine - July 1, 2019 Category: Pediatrics Tags: Neurocritical Care Source Type: research